Elevated levels of von Willebrand factor and high mobility group box 1 (HMGB1) are associated with disease severity and clinical outcome of scrub typhus

Int J Infect Dis. 2017 Aug:61:114-120. doi: 10.1016/j.ijid.2017.06.015. Epub 2017 Jun 23.

Abstract

Objectives: This study aimed to investigate whether von Willebrand factor (vWF) and high mobility group box 1 (HMGB1) are associated with the severity and clinical outcome of scrub typhus and to seek novel biomarkers for surveillance and prediction of the prognosis of this infection.

Methods: Serum concentrations of vWF and HMGB1 were measured twice by ELISA for scrub typhus patients (n=103), once prior to doxycycline therapy and then on day 7 of doxycycline therapy; concentrations were measured once for healthy controls (n=32).

Results: Among the total 103 patients enrolled, 38 had disease complicated by multiple organ dysfunction syndrome (MODS). Serum concentrations of vWF and HMGB1 were significantly higher in all the patients than in the healthy controls, both prior to doxycycline treatment and on day 7 of doxycycline treatment (p<0.01). Furthermore, serum levels of vWF, HMGB1, and creatinine (SCr) in the patients with MODS increased distinctly, while the platelet (PLT) count diminished markedly compared to the levels in patients without MODS (p<0.01). The concentration of vWF was positively correlated with that of HMGB1 (r=0.764, p<0.001) and SCr (r=0.528, p<0.001), but negatively correlated with the PLT count (r=-0.632, p<0.001). Both HMGB1 and vWF were significantly associated with mortality in scrub typhus (area under the curve (AUC)=0.864, p=0.001, and AUC=0.862, p=0.001, respectively).

Conclusions: Elevated levels of vWF and HMGB1 are associated with the severity and clinical outcome of scrub typhus. These represent possible new biomarkers for use in the assessment and prognostic prediction of this infection.

Keywords: High mobility group box 1; Multiple organ dysfunction syndrome; Scrub typhus; von Willebrand factor.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Biomarkers / blood
  • Doxycycline / therapeutic use
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • HMGB1 Protein / blood*
  • Humans
  • Male
  • Middle Aged
  • Multiple Organ Failure / etiology
  • Prognosis
  • Scrub Typhus / blood*
  • Scrub Typhus / drug therapy
  • Scrub Typhus / physiopathology
  • Treatment Outcome
  • von Willebrand Factor / metabolism*

Substances

  • Anti-Bacterial Agents
  • Biomarkers
  • HMGB1 Protein
  • von Willebrand Factor
  • Doxycycline